Both AChE and BChE enzymes are responsible for lowering the level of acetylcholine in the synaptic cleft of the brain leading to neurodegenerative disorders—namely, Alzheimer’s disease, Parkinson disease, and cognitive problems. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.